Inspyr Therapeutics Inc (OTC:NSPX) announced its quarterly earnings data on Monday, May 15th. The company reported ($0.45) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.17) by $0.28, Bloomberg Earnings reports.
Inspyr Therapeutics (OTC:NSPX) opened at 0.48505 on Tuesday. The firm’s market capitalization is $767349.06. Inspyr Therapeutics has a one year low of $0.30 and a one year high of $5.01. The company has a 50-day moving average of $0.49 and a 200 day moving average of $0.79.
Receive News & Ratings for Inspyr Therapeutics Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Inspyr Therapeutics Inc and related companies with our FREE daily email newsletter.